Generalized Anxiety Disorder (GAD) affects approximately 2–3% of the adult population, characterized by persistent anticipatory worry, tension, and 'background hum' of anxiety lasting weeks to months despite objective safety. Panic Disorder affects 1–2% of adults and presents as sudden, terrifying autonomic surges lasting 10–20 minutes with chest fluttering, air hunger, tremors, sweaty palms, and fear of imminent death despite cardiac investigations being normal. Both disorders reflect dysregulated sympathetic-parasympathetic balance: excessive sympathetic tone (fight-or-flight activation) coupled with impaired parasympathetic (vagal) brake that normally suppresses the stress response.
The physical manifestations of anxiety are real and distressing: heart palpitations, arrhythmias (benign ectopy), chest pressure or pain, breathing difficulty (air hunger), trembling, sweating, dizziness, and gastrointestinal hypermotility (nervous diarrhea, nausea, urgency) all arise from sympathetic over-drive. The 'gut-brain axis' is particularly evident in anxiety sufferers: neurological signals from the brain directly innervate the GI tract, causing anxiety to manifest as cramping, loose stools, and visceral distress that mimics irritable bowel syndrome (IBS). Many anxiety patients become convinced they have heart disease despite normal EKG and troponin levels—a phenomenon called 'cardiac neurosis' arising from heightened interoceptive awareness of benign palpitations.
Conventional management typically relies on selective serotonin reuptake inhibitors (SSRIs: escitalopram, sertraline) or benzodiazepines (alprazolam, clonazepam). Both classes carry significant drawbacks: SSRIs often take 4–8 weeks to work, carry sexual dysfunction and weight gain side effects, and create discontinuation syndromes upon stopping; benzodiazepines provide rapid relief but carry high abuse potential, cause cognitive dulling and daytime sedation, and create physical dependence within weeks of regular use—making discontinuation harrowing (rebound anxiety, tremor, seizure risk). Many patients become trapped in long-term benzodiazepine use despite repeated failed weaning attempts.
Constitutional homeopathic treatment takes a fundamentally different approach: instead of chemically manipulating neurotransmitters, homeopathy directly re-regulates the dysregulated autonomic nervous system tone underlying anxiety. Individualized constitutional remedies selected based on detailed case analysis (specific worry patterns, panic triggers, somatic manifestations, early-life anxiety precedents, sleep disturbance character, personality type) systematically normalize sympathetic-parasympathetic balance. As autonomic regulation improves, panic attack frequency declines (daily → weekly → rare → zero), GAD-7 scores drop markedly (baseline >10 → <5 by 4–6 weeks), sleep latency normalizes, and GI symptoms resolve. Crucially, homeopathic stabilization enables safe, physician-supervised benzodiazepine and SSRI tapering: every 2–3 weeks reduce medication dose by 10–25% as constitutional remedy efficacy stabilizes autonomic tone, achieving complete discontinuation within 8–12 weeks without rebound withdrawal.
At Gupta Computerised Homeopathic Clinic, Prof. Dr. (Mrs.) Neeraj Gupta combines detailed anxiety history (panic trigger identification, GAD-7 quantitative baseline, sleep assessment, medication history and prior weaning attempts), heart rate variability (HRV) assessment when available (parasympathetic tone evaluation), somatic symptom mapping (GI frequency, tremor severity, palpitation episodes), and comprehensive constitutional homeopathic case-taking to design individualized autonomic-regulatory remedies. With 30+ years of anxiety and benzodiazepine weaning expertise in Delhi and Ghaziabad, she provides in-person consultations at Shakarpur (East Delhi) and Vaishali (Ghaziabad) clinics, plus online consultations with home medicine delivery for outstation and international patients.